SANA
Sana Biotechnology Inc

4,121
Mkt Cap
$1.03B
Volume
19,886.00
52W High
$6.55
52W Low
$1.26
PE Ratio
-3.97
SANA Fundamentals
Price
$3.92
Prev Close
$3.85
Open
$3.85
50D MA
$4.49
Beta
2.00
Avg. Volume
2.53M
EPS (Annual)
-$1.16
P/B
5.17
Rev/Employee
$0.00
$314.22
Loading...
Loading...
News
all
press releases
Sana Biotechnology Announces Appointment Of Brian Piper As CFO
(RTTNews) - Sana Biotechnology, Inc. (SANA), Tuesday announced the appointment of Brian Piper as Executive Vice President and Chief Financial Officer of the company...
Nasdaq News: Markets·1d ago
News Placeholder
More News
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Downgraded by Wall Street Zen to Sell
Wall Street Zen lowered Sana Biotechnology from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·11d ago
News Placeholder
Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know
Does Sana Biotechnology (SANA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks·19d ago
News Placeholder
Sana Biotechnology, Inc. $SANA Position Boosted by Baillie Gifford & Co.
Baillie Gifford & Co. boosted its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA - Free Report) by 13.6% during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·24d ago
News Placeholder
Wall Street Analysts Think Sana (SANA) Could Surge 74.2%: Read This Before Placing a Bet
The consensus price target hints at a 74.2% upside potential for Sana (SANA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·26d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Trading Up 7.4% Following Analyst Upgrade
Sana Biotechnology (NASDAQ:SANA) Trading Up 7.4% on Analyst Upgrade...
MarketBeat·1mo ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Price Target Raised to $7.00 at Bank of America
Bank of America boosted their target price on shares of Sana Biotechnology from $6.00 to $7.00 and gave the stock a "buy" rating in a research report on Tuesday...
MarketBeat·1mo ago
News Placeholder
Three Genomics Stocks Worth Tracking This Year
Genomics advances are reshaping drug discovery, with Pacific Biosciences of California emerging as a key player in next-gen sequencing.
Zacks·1mo ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Shares Down 3.3% - Time to Sell?
Sana Biotechnology (NASDAQ:SANA) Trading Down 3.3% - Here's What Happened...
MarketBeat·2mo ago
News Placeholder
Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors
Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026...
Zero Hedge·2mo ago
<
1
2
...
>

Latest SANA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.